Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-03-06 Sale |
2023-03-08 4:16 pm |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
1,062 | $154.66 | $164,199 | 9,215 (Direct) |
View |
2022-12-13 Sale |
2022-12-15 4:34 pm |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
14,781 | $179.6 | $2,654,661 | 37,800 (Indirect Direct) |
View |
2022-11-30 Sale |
2022-12-02 4:32 pm |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
73,323 | $175.47 | $12,865,801 | 44,808 (Indirect Direct) |
View |
2022-11-22 Sale |
2022-11-23 4:44 pm |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
76,923 | $176.78 | $13,598,402 | 126,456 (Direct) |
View |
2022-11-18 Sale |
2022-11-21 4:33 pm |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
16,928 | $175 | $2,962,400 | 16,178 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-04-27 Option Award |
2023-05-02 5:20 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Adamczyk Darius Director |
1,194 | $0 | 2,259 (Direct) |
View |
Ownership |
2023-04-13 5:10 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Pharmaceuticals R&D |
0 | $0 | 306 (Direct) |
View |
2023-03-07 Option Award |
2023-03-09 5:41 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Washington A. Eugene Director |
201 | $155.16 | 28,569 (Direct) |
View |
2023-03-07 Option Award |
2023-03-09 5:41 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
234 | $155.16 | 6,431 (Direct) |
View |
Ownership |
2023-02-22 12:59 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Johnson Paula A Director |
0 | $0 | 100 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
8,578 | $162.01 | 146,057 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
114,365 | $0 | 146,057 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
4,891 | $162.01 | 113,004 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
45,109 | $0 | 113,004 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
10,569 | $162.01 | 208,130 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
89,962 | $0 | 208,130 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
918 | $162.01 | 33,809 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
26,760 | $0 | 33,809 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health |
6,430 | $162.01 | 125,887 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health |
73,682 | $0 | 125,887 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
7,158 | $162.01 | 122,847 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:24 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
82,993 | $0 | 122,847 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
4,586 | $162.01 | 131,613 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:24 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
53,506 | $0 | 131,613 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
5,765 | $162.01 | 171,359 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:24 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
61,131 | $0 | 171,359 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
13,599 | $162.01 | 499,881 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:24 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
213,978 | $0 | 499,881 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
397 | $162.01 | 26,320 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:24 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
10,144 | $0 | 26,320 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
924 | $162.01 | 39,754 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:24 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
36,825 | $0 | 39,754 (Direct) |
View |
2023-02-13 Tax Withholding |
2023-02-15 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
1,440 | $162.01 | 40,690 (Direct) |
View |
2023-02-13 Option Award |
2023-02-15 7:24 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
25,468 | $0 | 40,690 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:37 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
2,267 | $162.08 | 299,502 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:37 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
5,220 | $0 | 299,502 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:37 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
667 | $162.08 | 72,786 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:37 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
1,807 | $0 | 72,786 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
979 | $162.08 | 40,270 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:36 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
3,449 | $0 | 40,270 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
1,289 | $162.08 | 128,737 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:36 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
3,570 | $0 | 128,737 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
823 | $162.08 | 47,012 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:36 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
2,999 | $0 | 47,012 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:35 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
380 | $162.08 | 3,853 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:35 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
1,022 | $0 | 3,853 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:35 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
1,399 | $162.08 | 82,693 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:35 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
3,856 | $0 | 82,693 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:35 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health |
826 | $162.08 | 58,635 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:35 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health |
2,285 | $0 | 58,635 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:35 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
191 | $162.08 | 16,573 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:35 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
581 | $0 | 16,573 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:35 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
597 | $162.08 | 16,662 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:35 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
1,592 | $0 | 16,662 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:35 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
761 | $162.08 | 115,993 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:35 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
2,078 | $0 | 115,993 (Direct) |
View |
2022-02-14 Option Award |
2023-02-14 4:34 pm |
2025-02-14 2032-02-14 |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
19,368 | $165.89 | 29,296 (Direct) |
View |
2022-02-14 Option Award |
2023-02-14 4:34 pm |
2025-02-14 N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
1,961 | $0 | 29,296 (Direct) |
View |
2023-02-10 Tax Withholding |
2023-02-14 4:34 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
388 | $162.08 | 29,296 (Direct) |
View |
2023-02-10 Exercise |
2023-02-14 4:34 pm |
2023-02-10 N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
1,291 | $0 | 29,296 (Direct) |
View |
2023-01-17 Exercise |
2023-01-18 4:39 pm |
2016-01-17 2023-01-13 |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
547,692 | $72.54 | 768,336 (Direct) |
View |
2023-01-17 Tax Withholding |
2023-01-18 4:39 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Gorsky Alex Director |
366,610 | $173.43 | 768,336 (Direct) |
View |
2023-01-17 Exercise |
2023-01-18 4:39 pm |
2016-01-17 2023-01-13 |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
148,538 | $72.54 | 296,541 (Direct) |
View |
2023-01-17 Tax Withholding |
2023-01-18 4:39 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
98,795 | $173.43 | 296,541 (Direct) |
View |
2022-12-13 Exercise |
2022-12-15 4:34 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
1,855 | $72.54 | 37,800 (Direct) |
View |
2022-04-20 Gift |
2022-12-15 4:34 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
46 | $0 | 37,800 (Direct) |
View |
2022-12-13 Exercise |
2022-12-15 4:34 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
12,926 | $90.44 | 37,800 (Direct) |
View |
2022-12-13 Exercise |
2022-12-15 4:34 pm |
2016-01-17 2023-01-13 |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
14,781 | $0 | 37,800 (Direct) |
View |
2022-12-06 Option Award |
2022-12-08 4:45 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director |
241 | $178.7 | 6,276 (Direct) |
View |
2022-12-06 Option Award |
2022-12-08 4:45 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Washington A. Eugene Director |
351 | $178.7 | 28,163 (Direct) |
View |
2022-12-06 Option Award |
2022-12-08 4:45 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
240 | $178.7 | 6,152 (Direct) |
View |
2022-11-30 Exercise |
2022-12-02 4:32 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
73,323 | $72.54 | 44,808 (Direct) |
View |
2022-11-30 Exercise |
2022-12-02 4:32 pm |
2016-01-17 2023-01-13 |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
73,323 | $0 | 44,808 (Direct) |
View |
2022-11-22 Exercise |
2022-11-23 4:44 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
76,923 | $72.54 | 126,456 (Direct) |
View |
2022-11-22 Exercise |
2022-11-23 4:44 pm |
2016-01-17 2023-01-13 |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
76,923 | $0 | 126,456 (Direct) |
View |
2022-11-18 Exercise |
2022-11-21 4:33 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
16,928 | $90.44 | 16,178 (Direct) |
View |
2022-11-18 Exercise |
2022-11-21 4:33 pm |
2017-02-11 2024-02-09 |
JOHNSON & JOHNSON | JNJ | Decker Robert J Controller, CAO |
16,928 | $0 | 16,178 (Direct) |
View |
Ownership |
2022-11-14 2:44 pm |
N/A N/A |
MeiraGTx Holdings plc | MGTX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
0 | $0 | 6,641,064 (Indirect) |
View |